Related Experiment Video
Updated: Nov 25, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Characteristics of Vascular Phenotype in Fabry Patients
Andreja Cokan Vujkovac1, Bojan Vujkovac1, Srdjan Novaković2
1Department of Internal Medicine, 37672General Hospital Slovenj Gradec, Slovenj Gradec, Slovenia.
Insights
Fabry disease, a lysosomal disorder, causes significant vascular abnormalities including thickened artery walls and impaired endothelial function. These findings highlight a complex vascular phenotype in Fabry patients.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Lysosomal Storage Disorders
Background:
- Fabry disease is a rare X-linked lysosomal disorder caused by alpha-galactosidase A deficiency.
- This deficiency leads to glycosphingolipid accumulation, primarily in endothelial cells, impairing vascular morphology and function.
Purpose of the Study:
- To assess vascular wall hypertrophy, endothelial function, atherosclerotic plaque presence, and inflammatory biomarkers in Fabry patients compared to healthy controls.
- To characterize the vascular phenotype associated with Fabry disease.
Main Methods:
- Carotid artery intima-media thickness (cIMT) and brachial artery flow-mediated dilation (FMD) were measured.
- Atherosclerotic plaques in carotid and femoral arteries were assessed.
- Levels of endothelial adhesion molecules and inflammatory biomarkers were analyzed in 33 Fabry patients and 66 controls.
Main Results:
- Fabry patients exhibited significantly thicker cIMT, dilated common carotid arteries, and aortic annulus compared to controls.
- Reduced FMD and lower prevalence of atherosclerotic plaques were observed in Fabry patients.
- Elevated levels of vascular cell adhesion molecule-1, interleukin-6, tumor necrosis factor α, and high-sensitivity CRP, along with lower E-selectin, were found in Fabry patients.
Conclusions:
- Fabry disease is associated with a complex vascular phenotype, including structural and functional abnormalities.
- The findings suggest significant endothelial dysfunction and inflammation in Fabry patients.
- Further research into this vascular phenotype may yield important clinical applications for managing Fabry disease.
Abstract:
Fabry disease is a rare X-linked lysosomal disorder. Alpha-galactosidase A deficiency caused by mutation leads to accumulation of glycosphingolipids predominantly in endothelial cells, leading to impairment of vascular wall morphology and function. We assessed vascular wall hypertrophy (carotid artery intima-media thickness, cIMT), endothelial function (brachial artery flow-mediated dilation, FMD), presence of atherosclerotic plaques in the carotid and femoral arteries, and levels of endothelial adhesion and inflammatory biomarkers in 33 Fabry patients compared with 66 healthy matched controls. Fabry patients had thicker cIMT (0.07 ± 0.02 vs 0.06 ± 0.02 cm; P = .021), as well as dilated common carotid arteries (0.80 ± 0.12 vs 0.70 ± 0.06 cm; P < .001), and aortic annulus than controls (3.07 ± 0.48 vs 2.7 ± 0.48 cm; P = .001). Flow-mediated dilation was reduced (4.48 ± 8.80 vs 10.67 ± 8.72%; P = .001) and atherosclerotic plaques were less present in Fabry patients (9.10% vs 43.94%; P < .001). Vascular cell adhesion molecule-1, interleukin-6, tumor necrosis factor α, and high-sensitivity CRP were significantly higher and E-selectin lower in Fabry patients. Our results suggest that a complex vascular phenotype is present in Fabry patients. This represents a challenge for further research that could have important clinical applications.
More Related Videos
09:53Whole-mount Immunohistochemical Analysis for Embryonic Limb Skin Vasculature: a Model System to Study Vascular Branching Morphogenesis in Embryo
Published on: May 20, 2011
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Overview of the Vascular System
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...